• Cantor Fitzgerald Reaffirms Overweight Rating for ARS Pharmaceuticals (NASDAQ:SPRY)

    المصدر: Buzz FX / 08 أكتوبر 2024 12:21:10   America/New_York


    Cantor Fitzgerald Reaffirms Overweight Rating for ARS Pharmaceuticals (NASDAQ:SPRY) Written by MarketBeat October 8, 2024 Share Link copied to clipboard. ARS Pharmaceuticals ( NASDAQ:SPRY - Get Free Report ) 's stock had its "overweight" ra
    Read more...
شارك على،